市場調查報告書
商品編碼
1081069

麻醉及呼吸設備市場:現狀分析與預測(2021年∼2027年)

Anesthesia And Respiratory Devices Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

麻醉及呼吸設備的市場規模,在預測期間(2021年∼2027年)預計以7%的顯著年複合成長率擴大。該市場的成長,主要由於COPD、OSA等呼吸疾病增加,麻醉及呼吸設備管理的認識計劃劇增,老年人口增加所促進。

本報告提供麻醉及呼吸設備市場相關調查,市場現狀,以及各產品類型,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場簡介

第2章 調查手法或假設

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對麻醉及呼吸設備市場的影響

第6章 麻醉及呼吸設備市場收益,2019年∼2027年

第7章 各產品類型的市場洞察

  • 麻醉設備
    • 麻醉儀器
    • 麻醉監控器
    • 麻醉資訊管理系統
    • 其他
  • 呼吸設備
    • 呼吸設備
    • 呼吸系統用拋棄式
    • 呼吸檢測設備
    • 其他

第8章 各終端用戶的市場洞察

  • 醫院
  • 診所
  • 居家醫療設施
  • 門診病人手術中心

第9章 各地區的市場洞察

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章麻醉及呼吸設備市場市場動態

  • 市場促進因素
  • 市場課題
  • 影響分析

第11章麻醉及呼吸設備市場機會

第12章麻醉及呼吸設備市場趨勢

第13章 相關法規

第14章 需求面與供給方面的分析

  • 需求面分析
  • 供給方面分析

第15章 競爭模式

  • 競爭情形
    • 企業佔有率,各收益

第16章 企業概要

  • SunMed
  • Smiths Group plc
  • ResMed
  • Masimo
  • Koninklijke Philips N.V.
  • Invacare Corporation
  • Teleflex Incorporated
  • Hamilton Medical
  • GE Healthcare
  • Fisher & Paykel Healthcare Limited

第17章 免責聲明

目錄
Product Code: UMHE21814

Anesthesia and Respiratory Devices Market is anticipated display significant CAGR of 7% over the forecast period (2021-2027). The growth of the global anesthesia and respiratory devices market can be mainly attributed due to the rise in respiratory illnesses such as COPD, and OSA coupled with the surge in awareness programs for anesthesia and respiratory devices & management and the increasing geriatric population, thus contributing significantly to the growth of the market. According to the World Health Organization (WHO), every year about 65 million people suffer from COPD, 334 million people suffer from asthma and over 10 million people develop tuberculosis (TB) globally. Furthermore, the rising number of tobacco smokers will upsurge anesthesia and respiratory devices market size over the forecast timeframe. Smoking causes about 90% of all lung cancer deaths and thus smokers are more likely to die from COPD than non-smokers.

Some of the major players operating in the market include SunMed, Smiths Group plc, ResMed, Masimo, Koninklijke Philips N.V., Invacare Corporation, Teleflex Incorporated, Hamilton Medical, GE Healthcare, Fisher & Paykel Healthcare Limited.

The ongoing COVID-19 pandemic across the world have had a tremendous impact on different spectra of society, the market for anesthesia and respiratory devices is no less impacted by this. In the early phase of the pandemic, due to the increasing cases of COVID-19, all hospitals, globally, had canceled their scheduled and elective surgeries. Acute surgical emergencies were still inevitable and were being addressed in a timely and sensible manner. According to the report published by the British Journal of Surgery, in May 2020, an estimated 585,000 elective surgeries were postponed in the 12-week lockdown in India alone, and 28.4 million elective surgeries worldwide are expected to be canceled or postponed. Thus, the halt of surgical procedures is the major factor that is likely to hamper the usage of anesthesia and respiratory devices.

Insights Presented in the Report

"Amongst Product Type, Respiratory Devices segment dominated the market in 2020"

Based on product type, the market is bifurcated into anesthesia devices and respiratory devices. Amongst them, anesthesia devices is further categorized into anesthesia machines, monitors, and anesthetic information management systems. In addition, respiratory devices is further bifurcated into respiratory equipment, respiratory disposables, and respiratory measurement devices. Technological advancements in respiratory devices further offer segment growth opportunities. Additionally, the rising geriatric population that is prone to various respiratory conditions, increasing healthcare expenditure, and emerging market economies will offer growth potential for respiratory devices in the forthcoming period.

"Amongst End User, Diagnostic Centers category to witness fastest growth rate"

Based on end user, the market is bifurcated into hospitals, clinics, homecare settings, ambulatory surgical centers, and others. Among them, the hospital segment held the largest market share in 2020 and is further projected to maintain its leading position in the market during the forecast period. This is mainly due to the rising adoption of anesthesia and respiratory devices in healthcare settings coupled with growing investments by government and private healthcare facilities to update infrastructure and devices. Due to rising chronic diseases, healthcare facilities focus on providing better diagnoses and treatment of these diseases. As per the Pan American Health Organization, 75% of all hospitalized patients require supplemental oxygen treatment. Furthermore, the high demand for therapeutic devices for homecare settings and the launch of homecare devices by key players is also expected to provide lucrative growth opportunities for the market. For instance, In January 2019, Masimo received the FDA approval for MightSat Rx finger pulse oximeter that can be used at home. According to the Agency for Healthcare Research and Quality (AHRQ), in 2014, 17.2 million hospital visits resulted into at least one surgery.

"North America will Dominate the Market During the Forecast Period"

For a better understanding of the demand of Anesthesia and Respiratory Devices Market, the market is analyzed for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Currently, North America dominated the market in 2020. In North America, the enlarged availability of anesthesia and respiratory devices in hospitals coupled with an increased incidence of respiratory disorders and lifestyle-related diseases, are driving this market's development in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), about 40 million adults in the U.S., and about 4.7 million middle and early adolescence age individuals smoke at least one tobacco product every day, including e-cigarettes. Thus, the rising geriatric population, chronic diseases, and the number of surgeries with higher adoption and wide accessibility of advanced anesthesia and respiratory devices in the region is expected to drive the North American anesthesia and respiratory devices market.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The Anesthesia and Respiratory Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1.  MARKET INTRODUCTION

  • 1.1.    Market Definitions
  • 1.2.    Limitation
  • 1.3.    Stakeholders
  • 1.4.    Currency used in Report

2.  RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Anesthesia and Respiratory Devices Market
  • 2.2. Research Methodology of the Anesthesia and Respiratory Devices Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Anesthesia and Respiratory Devices Market Study

3.   MARKET SYNOPSIS

4.    EXECUTIVE SUMMARY

5.    ANESTHESIA AND RESPIRATORY DEVICES MARKET COVID-19 IMPACT

6.    ANESTHESIA AND RESPIRATORY DEVICES MARKET REVENUE, 2019-2027F

7.   MARKET INSIGHTS BY Product Type

  • 7.1. Anesthesia Devices
    • 7.1.1. Anesthesia Machines
    • 7.1.2. Anesthesia Monitors
    • 7.1.3. Anesthetic Information Management Systems
    • 7.1.4. Others
  • 7.2. Respiratory Devices
    • 7.2.1. Respiratory Equipment
    • 7.2.2. Respiratory Disposables
    • 7.2.3. Respiratory Measurement Devices
    • 7.2.4. Others

8.   MARKET INSIGHTS BY End User

  • 8.1. Hospitals
  • 8.2.   Clinics
  • 8.3.  Homecare Settings
  • 8.4.    Ambulatory Surgical Centers

9.   MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1.                      US US
    • 9.1.2.                      Canada Canada
    • 9.1.3.                      Rest of North America Rest of North America
  • 9.2.  Europe
    • 9.2.1.                      Germany Germany
    • 9.2.2.                      Germany UK
    • 9.2.3.                      Germany France
    • 9.2.4.                      Germany Italy
    • 9.2.5.                      Germany Spain
    • 9.2.6.                      Germany Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1.  China
    • 9.3.2.  Japan
    • 9.3.3.   India
    • 9.3.4. Australia
    • 9.3.5.  Rest of Asia-Pacific
  • 11.4.               Rest of World 9.4.  Rest of World

10 ANESTHESIA AND RESPIRATORY DEVICES MARKET DYNAMICS

  • 12.1.               Market Drivers 10.1.  Market Drivers
  • 12.2.               Market Challenges 10.2.  Market Challenges
  • 12.3.               Impact Analysis 10.3.   Impact Analysis

11 ANESTHESIA AND RESPIRATORY DEVICES MARKET OPPORTUNITIES

12.  ANESTHESIA AND RESPIRATORY DEVICES MARKET TRENDS

13.   LEGAL & REGULATORY FRAMEWORK

14.   DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis
    • 14.2.1.  Top Product Launches
    • 14.2.2.  Top Business Partnerships
    • 14.2.3.    Top Business Expansions
    • 14.2.4.  Top Merger and Acquisitions

15.  COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1.                  Company Shares, By Revenue

16.   COMPANY PROFILED COMPANY PROFILED

  • 16.1.  SunMed
  • 16.2. Smiths Group plc
  • 16.3. ResMed
  • 16.4.  Masimo
  • 16.5. Koninklijke Philips N.V.
  • 16.6. Invacare Corporation
  • 16.7. Teleflex Incorporated
  • 16.8. Hamilton Medical
  • 16.9. GE Healthcare
  • 16.10. Fisher & Paykel Healthcare Limited

17.   DISCLAIMER